Burgess, A
Daily Dosing: Comparing Convenience and Compliance FDA-Approved Oral Tablets: Must be taken first thing in the morning on an empty stomach Take with only 4 ounces of water or less Wait 30 minutes before eating, drinking anything else, or taking other medications Timing and fasting window are critical for absorption Requires daily compliance Compounded ODT Formulations: Dissolve under the tongue or in the cheek Taken once daily Generally no food/water restrictions (though specific instructions vary) May be more convenient than swallowed tablets Still requires daily compliance Injectable GLP-1s: Administered once weekly at any time of day Can be taken with or without food No fasting period required More forgiving if you're slightly late with your dose Studies show that patient preferences often shift once they understand these requirements
Think of it as creating a buffer zone around each molecule
Ingredients:Water, Butylene Glycol, Macadamia integrifolia Seed Oil, Centella asiatica Extract, PEG/PPG-19/19 Dimethicone, Cyclopentasiloxane, Glycereth-26, Cetyl PEG/PPG-10/1Dimethicone, Milk Protein Extract, Phenoxyethanol, Fragrance, Hyaluronic Acid, Glutathione, Betaine, 1,2-Hexanediol, Allantoin, Panthenol, Lavandula angustifolia (Lavender) Extract, Chamomilla Recutita (Matricaria) Flower Extract, Glycyrrhiza glabra (Licorice) Root Extract, Camellia sinensis Leaf Extract, Vitis vinifera (Grape) Seed Extract, Tocopheryl Acetate, Disodium EDTA, Salicylic Acid, Glycolic Acid
Avoid taking glutathione if you're sensitive to it
GLP-1 receptor activation The GLP-1 component of retatrutide reduces appetite through multiple mechanisms: slowing gastric emptying (food stays in your stomach longer, so you feel full sooner), signaling satiety centers in the brain (your brain gets a stronger "stop eating" signal), and enhancing insulin secretion in response to meals